WHEN SELECTING A NEW THERAPY, CHOOSE IDELVION

IDELVION OFFERS

checkmark image

Effective On-Demand Bleed Resolution

IDELVION resolves bleeds quickly, often in a single dose

checkmark image

Long-Lasting, Powerful Prophylactic Bleed Protection

In the IDELVION trial, adults and adolescents averaged 0 spontaneous and 0 joint bleeds per year when dosed every 7 or 14 days*

checkmark image

Individualized
Dosing Options

IDELVION has multiple dosing schedules, including 14-day prophylactic dosing, to meet varying needs

Learn more about switching to IDELVION

checkmark image
  • *Zero median annualized spontaneous and joint bleeding rate when dosed at 7 or 14 days in pivotal study.
  • Once well controlled (1 month without spontaneous bleeding or requiring dose adjustments on a weekly dose of ≤40 IU/kg), people 12 years and older can be transitioned to 14-day dosing.
  • Hemophilia FIX Market Assessment, Third-Party Market Research.
You are now leaving the current website.

Do you want to continue?

No Yes